Molecure Statistics

Total Valuation

Molecure has a market cap or net worth of PLN 120.12 million. The enterprise value is 103.24 million.

Market Cap	120.12M
Enterprise Value	103.24M

Important Dates

The next confirmed earnings date is Monday, May 18, 2026.

Earnings Date	May 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Molecure has 20.60 million shares outstanding. The number of shares has increased by 1.98% in one year.

Current Share Class	20.60M
Shares Outstanding	20.60M
Shares Change (YoY)	+1.98%
Shares Change (QoQ)	+21.28%
Owned by Insiders (%)	0.71%
Owned by Institutions (%)	12.29%
Float	14.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.42
PB Ratio	1.34
P/TBV Ratio	5.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.58
EV / Sales	15.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -16.27% and return on invested capital (ROIC) is -22.82%.

Return on Equity (ROE)	-16.27%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-22.82%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	9.74%
Revenue Per Employee	91,823
Profits Per Employee	-220,966
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.11% in the last 52 weeks. The beta is 1.08, so Molecure's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-31.11%
50-Day Moving Average	6.28
200-Day Moving Average	6.91
Relative Strength Index (RSI)	56.72
Average Volume (20 Days)	80,681

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Molecure had revenue of PLN 6.52 million and -15.69 million in losses. Loss per share was -0.76.

Revenue	6.52M
Gross Profit	-16.56M
Operating Income	-16.56M
Pretax Income	-15.69M
Net Income	-15.69M
EBITDA	-15.63M
EBIT	-16.56M
Loss Per Share	-0.76

Full Income Statement

Balance Sheet

The company has 22.46 million in cash and 5.58 million in debt, with a net cash position of 16.88 million or 0.82 per share.

Cash & Cash Equivalents	22.46M
Total Debt	5.58M
Net Cash	16.88M
Net Cash Per Share	0.82
Equity (Book Value)	89.43M
Book Value Per Share	4.34
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	926,568
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -253.99%, with operating and profit margins of -253.99% and -240.64%.

Gross Margin	-253.99%
Operating Margin	-253.99%
Pretax Margin	-240.64%
Profit Margin	-240.64%
EBITDA Margin	-239.77%
EBIT Margin	-253.99%
FCF Margin	n/a

Dividends & Yields

Molecure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.98%
Shareholder Yield	-1.98%
Earnings Yield	-13.06%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a